HCA — HCA Healthcare Cashflow Statement
0.000.00%
- $114.48bn
- $163.19bn
- $75.60bn
- 94
- 62
- 96
- 97
Annual cashflow statement for HCA Healthcare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 7,721 | 6,834 | 6,091 | 6,657 | 7,782 |
| Depreciation | |||||
| Non-Cash Items | -1,112 | -129 | 720 | 651 | 913 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -503 | -1,152 | -457 | -106 | 418 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | 8,959 | 8,522 | 9,431 | 10,514 | 12,636 |
| Capital Expenditures | -3,577 | -4,395 | -4,744 | -4,875 | -4,944 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 934 | 1,006 | -573 | -58 | -44 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2,643 | -3,389 | -5,317 | -4,933 | -4,988 |
| Financing Cash Flow Items | -1,071 | -1,290 | -917 | -1,055 | -1,091 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -6,655 | -5,656 | -4,094 | -4,582 | -8,550 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -342 | -543 | 27 | 998 | -893 |